Upstream Biosciences Inc. (UPBS) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Upstream Biosciences Inc. Company Snapshot

Business Description:

Upstream Biosciences Inc. operates in the Diagnostic substances sector. Upstream Biosciences Inc., is a development stage company engaged in the business of developing and commercializing genetic biomarkers and biotechnology drugs. The Company is developing genetic diagnostic biomarkers for use in determining a patient's susceptibility to disease and predicting a patient's response to drugs. The Company focuses its research on variations in the untranslated regions of the human genome. Variations in these regions can be used as diagnostic markers to predict or aid in the prediction of susceptibility to disease or to predict a patient's response to drugs. On August 24, 2007, the Company acquired 100% of Pacific Pharma Technologies Inc., a Canadian early stage biopharmaceutical company that has developed a technology platform that combines artificial intelligence, advanced computational methods and chemical diversity techniques to discover new drug candidates.

Stock Performance Chart for Upstream Biosciences Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/9/2012): .01
(Figures in U.S. Dollars)

1 Week	-1.8%	13 Weeks	0.0%

4 Weeks	-44.0%	52 Weeks	-81.3%

Upstream Biosciences Inc. Key Data:

Ticker:	UPBS	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2002 Sales	N/A (Year Ending Jan 2003).	Employees:	1

Currency:	U.S. Dollars	Market Cap:	191,028

Fiscal Yr Ends:	September	Shares Outstanding:	34,112,065

Share Type:	Common	Closely Held Shares:	6,800,000

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.